Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia: An Open-Label Extension Study of a Randomized Clinical Trial | 0 | 27 | July 17, 2024 | |
| Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia | 0 | 774 | April 1, 2015 | |
| Long-Acting Schizophrenia Tx Shows Long-Term Safety With Limited Relapses | 1 | 226 | September 11, 2023 | |
| Most Patients With Schizophrenia Relapse-Free With Paliperidone Palmitate, Open Label Extension Study Finds | 3 | 38 | August 2, 2024 | |
| Long-acting injectable paliperidone palmitate for schizophrenia | 4 | 975 | May 27, 2016 |